Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of dr alexander elder trading for a living proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1.
- Since then, IOBCF shares have decreased by 41.2% and is now trading at $9.86.
- Style is calculated by combining value and growth scores, which are first individually calculated.
- The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments.
- High-growth stocks tend to represent the technology, healthcare, and communications sectors.
Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium. High-growth stocks tend to represent the technology, healthcare, and communications sectors. how to buy algorand They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks.
About MarketBeat
Since then, IOBCF shares have decreased by 41.2% and is now trading at $9.86. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we best forex signal provider have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data. Please log in to your account or sign up in order to add this asset to your watchlist. One share of IOBCF stock can currently be purchased for approximately $9.86.
Ion Beam Applications SA Analysis
Ion Beam Applications saw a decline in short interest during the month of September. As of September 15th, there was short interest totaling 1,700 shares, a decline of 72.6% from the August 31st total of 6,200 shares. Based on an average trading volume of 1,700 shares, the days-to-cover ratio is presently 1.0 days. MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. We’d like to share more about how we work and what drives our day-to-day business. IOBCF’s beta can be found in Trading Information at the top of this page.
Research & Ratings Ion Beam Applications S.A.(IBAB)
Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes. Data may be intentionally delayed pursuant to supplier requirements. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer. Ion Beam Applications’ stock was trading at $16.78 at the start of the year.